Pemgarda (formerly VYD222) a Pre-Exposure Prop... - CLL Support
Pemgarda (formerly VYD222) a Pre-Exposure Prophylaxis (PREP) of COVID-19 has been granted Emergency Use Authorization in the US
You need to be a member of this community to see this post.
Read more about...
27 Replies
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
Emergency use authorization of a new pre-exposure prophylaxis (PrEP) for COVID-19, PEMGARDA™ (VYD222)
Hi,
Great news for the immunocompromised community including us. Invivyd announced late last week...
The FDA has authorized the Emergency use of REGEN-COV for the treatment of COVID-19
For those who don't know; The FDA has authorized the emergency use of REGEN-COV for the treatment...
Important SARS-CoV-2 and Covid-19 information for Chronic Lymphocytic Leukaemia/CLL patients
This post, prepared in collaboration with @[52122] , draws together some earlier posts...
Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T
We evaluated 254 COVID-19 patients longitudinally from early infection and for eight months...
Related Posts
The new, more infectious strain of Covid may originate in immunocompromised patients- Research shows blood cancer patients generate strong T cell immunity after SARS-CoV-2 vaccination
COVID-19 PrEP A single dose of Regen-Cov® may be effective for pre-exposure prophylaxis (PrEP) without needing 
Which monoclonal antibody would work with omicron covid 19?
COVID TEST - NO ANTIBODIES AT ALL?
